Topics

Update Sustains OS Benefit of Chemohormonal Therapy in High-Volume Prostate Cancer

10:40 EST 2 Feb 2018 | OncLive

Adding docetaxel to androgen-deprivation therapy improved overall survival by nearly 17 months in men with high-volume metastatic hormone-sensitive prostate cancer.

Original Article: Update Sustains OS Benefit of Chemohormonal Therapy in High-Volume Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Update Sustains OS Benefit of Chemohormonal Therapy in High-Volume Prostate Cancer"

Quick Search

Relevant Topic

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...